SOPHiA GENETICS
SOPH
30 hedge funds and large institutions have $65.2M invested in SOPHiA GENETICS in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.
2,000% more call options, than puts
Call options by funds: $21K | Put options by funds: $1K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.07% less ownership
Funds ownership: 27.41% → 27.34% (-0.07%)
3% less funds holding
Funds holding: 31 → 30 (-1)
21% less capital invested
Capital invested by funds: $82.1M → $65.2M (-$16.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AKRE Capital Management
Middleburg,
Virginia
|
+$1.29M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$353K |
| 3 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
+$187K |
| 4 |
GAA
Green Alpha Advisors
Niwot,
Colorado
|
+$87.5K |
| 5 |
Squarepoint
New York
|
+$79.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.4M |
| 2 |
LCM
Legato Capital Management
San Francisco,
California
|
-$477K |
| 3 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$339K |
| 4 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$55K |
| 5 |
Morgan Stanley
New York
|
-$52.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $2.56K | – | – | – |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | -$61 | -15 | -2% |
|
|
PS
28
Principal Securities
Des Moines,
Iowa
| $1.76K | +$1.57K | +387 | +412% |
|
29
Russell Investments Group
London,
United Kingdom
| $190 | – | – | – |
|
30
Citigroup
New York
| $55 | – | – | – |
|
|
EIM
31
Essex Investment Management
Boston,
Massachusetts
| – | -$1.4M | -305,338 | Closed |
|
|
LCM
32
Legato Capital Management
San Francisco,
California
| – | -$477K | -104,083 | Closed |
|
|
BCV
33
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$55K | -12,000 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$160 | -35 | Closed |
|
SOPH Hedge Fund Activity: Q3 2024 in Review
30 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q3 2024, worth a combined $65.2M — down 21% from $82.1M a quarter earlier.
Fund positioning in SOPH was balanced in Q3 2024: 4 funds opened new positions, 4 closed out, 8 added to existing stakes and 8 trimmed.
The largest buyer was AKRE Capital Management, adding an estimated $1.29M. The largest seller was Essex Investment Management, exiting entirely with an estimated $1.4M sold.
- 30 institutional investors held SOPHiA GENETICS (SOPH) as of Q3 2024, down from 31 in Q2 2024.
- Funds reported $65.2M of SOPHiA GENETICS stock for Q3 2024, down 21% quarter-over-quarter.
- 4 funds opened new SOPHiA GENETICS positions in Q3 2024 and 4 closed out, a net change of 0 holders.
- The largest SOPHiA GENETICS buyer in Q3 2024 was AKRE Capital Management, an estimated $1.29M added.
- The largest SOPHiA GENETICS seller in Q3 2024 was Essex Investment Management, an estimated $1.4M sold.
Based on aggregated 13F filings for Q3 2024.